Transient Extremity Ischemia Augments CD34+ Progenitor Cell Availability

Stem Cell Reviews and Reports

Volumn 7, Issue 3, 2011, Pages 639-645

  Czeiger, David ^a,b   Dukhno, Oleg ^a,b   Douvdevani, Amos ^a,b   Porat, Yael ^c   Shimoni, Daphna ^c   Fulga, Valentin ^c   Ament, Jared D ^d   Shaked, Gad ^a,b  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c Theravitae Inc   (Israel)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Endothelial progenitor cells; Ischemic preconditioning; Stem cells

Indexed keywords

BIOLOGICAL MARKER; CD34 ANTIGEN; INTERLEUKIN 8; NITRIC OXIDE; VASCULOTROPIN A;

ANGIOGENESIS; ARTICLE; BLOOD; CYTOLOGY; HUMAN; ISCHEMIA; ISCHEMIC PRECONDITIONING; LIMB; METABOLISM; PHYSIOLOGY; STEM CELL; VASCULARIZATION;

ANTIGENS, CD34; BIOLOGICAL MARKERS; EXTREMITIES; HUMANS; INTERLEUKIN-8; ISCHEMIA; ISCHEMIC PRECONDITIONING; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE; STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79960293867     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-011-9234-x     Document Type: Article

References (38)

1. Rosenzweig, A. (2006). Cardiac cell therapy-mixed results from mixed cells. The New England Journal of Medicine, 355, 1274-7.
2. Kawamura, A., Horie, T., Tsuda, I., et al. (2006). Clinical study of therapeutic angiogenesis by autologous peripheral blood stem cell (PBSC) transplantation in 92 patients with critically ischemic limbs. Journal of Artificial Organs, 9, 226-33.
3. Wollert, K. C., Meyer, G. P., Lotz, J., et al. (2004). Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet, 364, 141-8.
4. Schachinger, V., Assmus, B., Britten, M. B., et al. (2004). Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. Journal of the American College of Cardiology, 44, 1690-9.
5. Chen, S. L., Fang, W. W., Ye, F., et al. (2004). Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. The American Journal of Cardiology, 94, 92-5.
6. Strauer, B. E., Brehm, M., Zeus, T., et al. (2002). Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation, 106, 1913-8.
7. Fukumoto, Y., Miyamoto, T., Okamura, T., et al. (1997). Angina pectoris occurring during granulocyte colony-stimulating factor-combined preparatory regimen for autologous peripheral blood stem cell transplantation in a patient with acute myelogenous leukaemia. British Journal Haematology, 97, 666-8.
8. Hill, J. M., Syed, M. A., Arai, A. E., et al. (2005). Outcomes and risks of granulocyte colony-stimulating factor in patients with coronary artery disease. Journal of the American College of Cardiology, 46, 1643-8.
9. Matsubara, H. (2004). Risk to the coronary arteries of intracoronary stem cell infusion and G-CSF cytokine therapy. Lancet, 363, 746-7.
10. Kalka, C., Masuda, H., Takahashi, T., et al. (2000). Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proceedings of the National Academy of Sciences of the United States of America, 97, 3422-7.
11. Vasa, M., Fichtlscherer, S., Adler, K., et al. (2001). Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation, 103, 2885-90.
12. Steiner, S., Niessner, A., Ziegler, S., et al. (2005). Endurance training increases the number of endothelial progenitor cells in patients with cardiovascular risk and coronary artery disease. Atherosclerosis, 181, 305-10.
13. Sandri, M., Adams, V., Gielen, S., et al. (2005). Effects of exercise and ischemia on mobilization and functional activation of blood-derived progenitor cells in patients with ischemic syndromes: results of 3 randomized studies. Circulation, 111, 3391-9.
14. Rehman, J., Li, J., Parvathaneni, L., et al. (2004). Exercise acutely increases circulating endothelial progenitor cells and monocyte-/macrophage-derived angiogenic cells. Journal of the American College of Cardiology, 43, 2314-8.
15. Shinsato, T., Miyata, M., Kubozono, T., et al. (2010). Waon therapy mobilizes CD34+ cells and improves peripheral arterial disease. Journal of Cardiology, 56, 361-6.
16. Porat, Y., Porozov, S., Belkin, D., et al. (2006). Isolation of an adult blood-derived progenitor cell population capable of differentiation into angiogenic, myocardial and neural lineages. British Journal Haematology, 135, 703-14.
17. Kayisli, U. A., Luk, J., Guzeloglu-Kayisli, O., Seval, Y., Demir, R., & Arici, A. (2004). Regulation of angiogenic activity of human endometrial endothelial cells in culture by ovarian steroids. The Journal of Clinical Endocrinology and Metabolism, 89, 5794-802.
18. Mukai, N., Akahori, T., Komaki, M., et al. (2008). A comparison of the tube forming potentials of early and late endothelial progenitor cells. Experimental Cell Research, 314, 430-40.
19. Assmus, B., Honold, J., Schachinger, V., et al. (2006). Transcoronary transplantation of progenitor cells after myocardial infarction. The New England Journal of Medicine, 355, 1222-32.
20. Strauer, B. E., Brehm, M., Zeus, T., et al. (2005). Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease: the IACT Study. Journal of the American College of Cardiology, 46, 1651-8.
21. Fuchs, S., Kornowski, R., Weisz, G., et al. (2006). Safety and feasibility of transendocardial autologous bone marrow cell transplantation in patients with advanced heart disease. The American Journal of Cardiology, 97, 823-9.
22. Erbs, S., Linke, A., Adams, V., et al. (2005). Transplantation of blood-derived progenitor cells after recanalization of chronic coronary artery occlusion: first randomized and placebo-controlled study. Circulation Research, 97, 756-62.
23. Kang, H. J., Lee, H. Y., Na, S. H., et al. (2006). Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial. Circulation, 114, I145-51.
24. Wilson, R. F., & Henry, T. D. (2005). Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: double-edged swords. Journal of the American College of Cardiology, 46, 1649-50.
25. Sesti, C., Hale, S. L., Lutzko, C., & Kloner, R. A. (2005). Granulocyte colony-stimulating factor and stem cell factor improve contractile reserve of the infarcted left ventricle independent of restoring muscle mass. Journal of the American College of Cardiology, 46, 1662-9.
26. Losordo, D. W., Schatz, R. A., White, C. J., et al. (2007). Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial. Circulation, 115, 3165-72.
27. Turan, R. G., Brehm, M., Koestering, M., et al. (2007). Factors influencing spontaneous mobilization of CD34+ and CD133+ progenitor cells after myocardial infarction. Eur J Clin Invest, 37, 842-51.
28. Shintani, S., Murohara, T., Ikeda, H., et al. (2001). Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation, 103, 2776-9.
29. Kamota, T., Li, T. S., Morikage, N., et al. (2009). Ischemic pre-conditioning enhances the mobilization and recruitment of bone marrow stem cells to protect against ischemia/reperfusion injury in the late phase. Journal of the American College of Cardiology, 53, 1814-22.
30. Smadja, D. M., Bieche, I., Susen, S., et al. (2008). Interleukin 8 is differently expressed and modulated by PAR-1 activation in early and late endothelial progenitor cells. Journal of Cellular Molecular Medicine.
31. Schomig, K., Busch, G., Steppich, B., et al. (2006). Interleukin-8 is associated with circulating CD133+ progenitor cells in acute myocardial infarction. European Heart Journal, 27, 1032-7.
32. Przyklenk, K., Bauer, B., Ovize, M., Kloner, R. A., & Whittaker, P. (1993). Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation, 87, 893-9.
33. Kharbanda, R. K., Mortensen, U. M., White, P. A., et al. (2002). Transient limb ischemia induces remote ischemic preconditioning in vivo. Circulation, 106, 2881-3.
34. Kanoria, S., Jalan, R., Seifalian, A. M., Williams, R., & Davidson, B. R. (2007). Protocols and mechanisms for remote ischemic preconditioning: a novel method for reducing ischemia reperfusion injury. Transplantation, 84, 445-58.
35. Kimura, M., Ueda, K., Goto, C., et al. (2007). Repetition of ischemic preconditioning augments endothelium-dependent vasodilation in humans: role of endothelium-derived nitric oxide and endothelial progenitor cells. Arteriosclerosis, Thrombosis, and Vascular Biology, 27, 1403-10.
36. Barsheshet, A., Hod, H., Shechter, M., et al. (2008). The effects of external counter pulsation therapy on circulating endothelial progenitor cells in patients with angina pectoris. Cardiology, 110, 160-6.
37. Wang, J. A., Chen, T. L., Jiang, J., et al. (2008). Hypoxic preconditioning attenuates hypoxia/reoxygenation-induced apoptosis in mesenchymal stem cells. Acta Pharmacologica Sinica, 29, 74-82.
38. Haider, H. K., & Ashraf, M. (2008). Strategies to promote donor cell survival: combining preconditioning approach with stem cell transplantation. Journal of Molecular and Cellular Cardiology, 45, 554-66.